Amlodipine Besylate Tablet
Product Images NDC 43353-989

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 43353-989). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10mg (43353 989)

Bottle Label 10mg (43353 989)
The text describes a medication named "Amlodipine Besylate" in the form of 30 tablets with a 10 mg dosage.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
This is a statistical analysis output for an event rate. It includes information about the p-value, hazard ratio, and confidence intervals. It also includes a graph which seems to show the event rate over time in months. However, the information provided is incomplete and it is hard to provide a full description without further details.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
This appears to be a table or graph of data related to a clinical trial study comparing Favars Amlodipine and Placebo in individuals with some form of vessel disease who may or may not have undergone PCI-stent treatment. The table includes information on the gender, sitting SEP, number of vessels with stenosis, and PCI-stent strata of the participants. The graph seems to show the hazard ratio for the two treatments over time, with a baseline sitting SEP of 120 mmHg.*
FDA Label Image

Structure (Ima)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.